Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clindamycin for Neurologic Complications in Neurosurgery and Meningitis
NCT06068673Completed
- Sponsor
- Damanhour University
- Start
- Mar 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of clindamycin (2 arms), sponsored by Damanhour University. Primary endpoints: Neuron-specific enolase Blood Concentration at 2 weeks and Neurotensin Blood Concentration at 2 weeks. Started Mar 2023; status: completed.
02
Drugs
clindamycin
Beyond the preview
Go deeper on NCT06068673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06068673.